abstract |
Glass solution or glass suspension of saxagliptin base, or pharmaceutically acceptable salt thereof, dispersed within a polymer matrix, wherein the polymer is selected from polyvinylpyrrolidone, hydroxypropyl methylcellulose and hydroxypropylcellulose. |